Exploring the roles of PALB2 at the crossroads of DNA repair and cancer

Biochemical Journal

Volumn 460, Issue 3, 2014, Pages 331-342

  Pauty, Joris ^a,b   Rodrigue, Amélie ^a,b   Couturier, Anthony ^a,b   Buisson, Rémi ^c   Masson, Jean Yves ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Double strand break repair; Fanconi's anaemia; Genome integrity; Partner and localizer of BRCA2 (PALB2)

Indexed keywords

BRCA2 PROTEIN; MRG15 PROTEIN; PARTNER AND LOCALIZER OF BREAST CANCER EARLY ONSET 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; DISEASE ASSOCIATION; DNA REPAIR; FANCONI ANEMIA; GENE MUTATION; GENOME; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; MALE BREAST CANCER; NEOPLASM; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SYNTHESIS; TUMOR SUPPRESSOR GENE;

ANIMALS; BRCA2 PROTEIN; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; DNA REPAIR; FANCONI ANEMIA; FEMALE; HOMOLOGOUS RECOMBINATION; HUMANS; MALE; MICE; NEOPLASMS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84901713506     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140208     Document Type: Review

References (113)

1. Lindahl, T. and Barnes, D. E. (2000) Repair of endogenous DNA damage. Cold Spring Harb. Symp. Quant. Biol. 65, 127-133 CrossRef PubMed (Pubitemid 32611934)
2. Shrivastav, M., De Haro, L. P. and Nickoloff, J. A. (2008) Regulation of DNA double-strand break repair pathway choice. Cell Res. 18, 134-147 CrossRef PubMed
3. Polo, S. E. and Jackson, S. P. (2011) Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 25, 409-433 CrossRef PubMed
4. Sonoda, E., Hochegger, H., Saberi, A., Taniguchi, Y. and Takeda, S. (2006) Differential usage of non-homologous end-joining and homologous recombination in double strand break repair. DNA Repair (Amst). 5, 1021-1029 CrossRef PubMed (Pubitemid 44291617)
5. Arnaudeau, C., Lundin, C. and Helleday, T. (2001) DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J. Mol. Biol. 307, 1235-1245 CrossRef PubMed (Pubitemid 33027636)
6. Moldovan, G. L. and D'Andrea, A. D. (2009) How the Fanconi anemia pathway guards the genome. Annu. Rev. Genet. 43, 223-249 CrossRef PubMed
7. Kee, Y. and D'Andrea, A. D. (2010) Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev. 24, 1680-1694 CrossRef PubMed
8. Garner, E. and Smogorzewska, A. (2011) Ubiquitylation and the Fanconi anemia pathway. FEBS Lett. 585, 2853-2860 CrossRef PubMed
9. Moynahan, M. E. and Jasin, M. (2010) Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat. Rev. Mol. Cell Biol. 11, 196-207 CrossRef PubMed
10. Nimonkar, A. V., Genschel, J., Kinoshita, E., Polaczek, P., Campbell, J. L., Wyman, C., Modrich, P. and Kowalczykowski, S. C. (2011) BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair. Genes Dev. 25, 350-362 CrossRef PubMed
11. Maréchal, A. and Zou, L. (2013) DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb. Perspect. Biol. 5, a012716 CrossRef PubMed
12. West, S. C. (2003) Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol. 4, 435-445 CrossRef PubMed (Pubitemid 36648589)
13. Conway, A. B., Lynch, T. W., Zhang, Y., Fortin, G. S., Fung, C. W., Symington, L. S. and Rice, P. A. (2004) Crystal structure of a Rad51 filament. Nat. Struct. Mol. Biol. 11, 791-796 CrossRef PubMed (Pubitemid 39014506)
14. Ogawa, T., Yu, X., Shinohara, A. and Egelman, E. H. (1993) Similarity of the yeast Rad51 filament to the bacterial RecA filament. Science 259, 1896-1899 CrossRef PubMed (Pubitemid 23124460)
15. San Filippo, J., Sung, P. and Klein, H. (2008) Mechanism of eukaryotic homologous recombination. Annu. Rev. Biochem. 77, 229-257 CrossRef PubMed
16. Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D. et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088-2090 CrossRef PubMed (Pubitemid 24325690)
17. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C. and Micklem, G. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792 CrossRef PubMed (Pubitemid 26004412)
18. Foulkes, W. D. (2008) Inherited susceptibility to common cancers. N. Engl. J. Med. 359, 2143-2153 CrossRef PubMed
19. Roy, R., Chun, J. and Powell, S. N. (2012) BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat. Rev. Cancer 12, 68-78 CrossRef
20. Moynahan, M. E., Pierce, A. J. and Jasin, M. (2001) BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell 7, 263-272 CrossRef PubMed (Pubitemid 32206494)
21. Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, S. S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P. and Bradley, A. (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804-810 CrossRef PubMed (Pubitemid 27181248)
22. Chen, J. J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M. and Scully, R. (1998) Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2, 317-328 CrossRef PubMed (Pubitemid 128379272)
23. Marmorstein, L. Y., Ouchi, T. and Aaronson, S. A. (1998) The BRCA2 gene product functionally interacts with p53 and Rad51. Proc. Natl. Acad. Sci. U.S.A. 95, 13869-13874 CrossRef PubMed (Pubitemid 28523065)
24. Davies, A. A., Masson, J. Y., McIlwraith, M. J., Stasiak, A. Z., Stasiak, A., Venkitaraman, A. R. and West, S. C. (2001) Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell 7, 273-282 CrossRef PubMed (Pubitemid 32206495)
25. Yuan, S.-S. F., Lee, S.-Y., Chen, G., Song, M., Tomlinson, G. E. and Lee, E. Y. (1999) BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res. 59, 3547-3551 PubMed (Pubitemid 29381849)
26. Yang, H., Jeffrey, P. D., Miller, J., Kinnucan, E., Sun, Y., Thoma, N. H., Zheng, N., Chen, P. L., Lee, W. H. and Pavletich, N. P. (2002) BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297, 1837-1848 CrossRef PubMed (Pubitemid 35024337)
27. San Filippo, J., Chi, P., Sehorn, M. G., Etchin, J., Krejci, L. and Sung, P. (2006) Recombination mediator and Rad51 targeting activities of a human BRCA2 polypeptide. J. Biol. Chem. 281, 11649-11657 CrossRef PubMed (Pubitemid 43855422)
28. Siaud, N., Barbera, M. A., Egashira, A., Lam, I., Christ, N., Schlacher, K., Xia, B. and Jasin, M. (2011) Plasticity of BRCA2 function in homologous recombination: genetic interactions of the PALB2 and DNA binding domains. PLoS Genet. 7, e1002409 CrossRef PubMed
29. Saeki, H., Siaud, N., Christ, N., Wiegant, W. W., van Buul, P. P., Han, M., Zdzienicka, M. Z., Stark, J. M. and Jasin, M. (2006) Suppression of the DNA repair defects of BRCA2-deficient cells with heterologous protein fusions. Proc. Natl. Acad. Sci. U.S.A. 103, 8768-8773 CrossRef PubMed (Pubitemid 43878094)
30. Jensen, R. B., Carreira, A. and Kowalczykowski, S. C. (2010) Purified human BRCA2 stimulates RAD51-mediated recombination. Nature 467, 678-683 CrossRef PubMed
31. Liu, J., Doty, T., Gibson, B. and Heyer, W. D. (2010) Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA. Nat. Struct. Mol. Biol. 17, 1260-1262 CrossRef PubMed
32. Thorslund, T., McIlwraith, M. J., Compton, S. A., Lekomtsev, S., Petronczki, M., Griffith, J. D. and West, S. C. (2010) The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA. Nat. Struct. Mol. Biol. 17, 1263-1265 CrossRef PubMed
33. Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J. and Livingston, D. M. (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell 22, 719-729 CrossRef PubMed
34. Tischkowitz, M. and Xia, B. (2010) PALB2/FANCN: recombining cancer and Fanconi anemia. Cancer Res. 70, 7353-7359 CrossRef PubMed
35. Ma, J., Cai, H., Wu, T., Sobhian, B., Huo, Y., Alcivar, A., Mehta, M., Cheung, K. L., Ganesan, S., Kong, A. N. et al. (2012) PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function. Mol. Cell. Biol. 32, 1506-1517 CrossRef PubMed
36. Buisson, R., Dion-Cote, A. M., Coulombe, Y., Launay, H., Cai, H., Stasiak, A. Z., Stasiak, A., Xia, B. and Masson, J. Y. (2010) Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination. Nat. Struct. Mol. Biol. 17, 1247-1254 CrossRef PubMed
37. Dray, E., Etchin, J., Wiese, C., Saro, D., Williams, G. J., Hammel, M., Yu, X., Galkin, V. E., Liu, D., Tsai, M. S. et al. (2010) Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2. Nat. Struct. Mol. Biol. 17, 1255-1259 CrossRef PubMed
38. Sy, S. M., Huen, M. S., Zhu, Y. and Chen, J. (2009) PALB2 regulates recombinational repair through chromatin association and oligomerization. J. Biol. Chem. 284, 18302-18310 CrossRef PubMed
39. Zhang, F., Fan, Q., Ren, K. and Andreassen, P. R. (2009) PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol. Cancer Res. 7, 1110-1118 CrossRef PubMed
40. Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B. and Yu, X. (2009) PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr. Biol. 19, 524-529 CrossRef PubMed
41. Buisson, R. and Masson, J. Y. (2012) PALB2 self-interaction controls homologous recombination. Nucleic Acids Res. 40, 10312-10323 CrossRef PubMed
42. Sy, S. M., Huen, M. S. and Chen, J. (2009) PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc. Natl. Acad. Sci. U.S.A. 106, 7155-7160 CrossRef PubMed
43. Oliver, A. W., Swift, S., Lord, C. J., Ashworth, A. and Pearl, L. H. (2009) Structural basis for recruitment of BRCA2 by PALB2. EMBO Rep. 10, 990-996 CrossRef PubMed
44. Metzger, M. J., Stoddard, B. L. and Monnat, Jr, R. J. (2013) PARP-mediated repair, homologous recombination, and back-up non-homologous end joining-like repair of single-strand nicks. DNA Repair (Amst). 12, 529-534 CrossRef PubMed
45. Park, J. Y., Singh, T. R., Nassar, N., Zhang, F., Freund, M., Hanenberg, H., Meetei, A. R. and Andreassen, P. R. (2013) Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair. Oncogene, doi: 10.1038/onc.2013.421 CrossRef
46. Buisson, R., Niraj, J., Pauty, J., Maity, R., Zhao, W., Coulombe, Y., Sung, P. and Masson, J. Y. (2014) Breast cancer proteins PALB2 and BRCA2 stimulate polymerase eta in recombination-associated DNA synthesis at blocked replication forks. Cell Rep. 6, 553-564 CrossRef PubMed
47. Bleuyard, J. Y., Buisson, R., Masson, J. Y. and Esashi, F. (2012) ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair. EMBO Rep. 13, 135-141 CrossRef PubMed
48. Hayakawa, T., Zhang, F., Hayakawa, N., Ohtani, Y., Shinmyozu, K., Nakayama, J. and Andreassen, P. R. (2010) MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks. J. Cell Sci. 123, 1124-1130 CrossRef PubMed
49. Sy, S. M., Huen, M. S. and Chen, J. (2009) MRG15 is a novel PALB2 interacting factor involved in homologous recombination. J. Biol. Chem. 284, 21127-21131 CrossRef PubMed
50. Doyon, Y. and Cote, J. (2004) The highly conserved and multifunctional NuA4 HAT complex. Curr. Opin. Genet. Dev. 14, 147-154 CrossRef PubMed (Pubitemid 38520142)
51. Yochum, G. S. and Ayer, D. E. (2002) Role for the mortality factors MORF4, MRGX, and MRG15 in transcriptional repression via associations with Pf1, mSin3A, and transducin-like enhancer of split. Mol. Cell. Biol. 22, 7868-7876 CrossRef PubMed (Pubitemid 35217297)
52. Hayakawa, T., Ohtani, Y., Hayakawa, N., Shinmyozu, K., Saito, M., Ishikawa, F. and Nakayama, J. (2007) RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation. Genes Cells 12, 811-826 PubMed (Pubitemid 46952553)
53. Zhang, P., Du, J., Sun, B., Dong, X., Xu, G., Zhou, J., Huang, Q., Liu, Q., Hao, Q. and Ding, J. (2006) Structure of human MRG15 chromo domain and its binding to Lys36-methylated histone H3. Nucleic Acids Res. 34, 6621-6628 CrossRef PubMed (Pubitemid 46017956)
54. Carrozza, M. J., Li, B., Florens, L., Suganuma, T., Swanson, S. K., Lee, K. K., Shia, W. J., Anderson, S., Yates, J., Washburn, M. P. and Workman, J. L. (2005) Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123, 581-592 CrossRef PubMed (Pubitemid 41608462)
55. Pardo, P. S., Leung, J. K., Lucchesi, J. C. and Pereira-Smith, O. M. (2002) MRG15, a novel chromodomain protein, is present in two distinct multiprotein complexes involved in transcriptional activation. J. Biol. Chem. 277, 50860-50866 CrossRef PubMed (Pubitemid 36042252)
56. Garcia, S. N., Kirtane, B. M., Podlutsky, A. J., Pereira-Smith, O. M. and Tominaga, K. (2007) Mrg15 null and heterozygous mouse embryonic fibroblasts exhibit DNA-repair defects post exposure to gamma ionizing radiation. FEBS Lett. 581, 5275-5281 CrossRef PubMed (Pubitemid 350018755)
57. Fierz, B., Chatterjee, C., McGinty, R. K., Bar-Dagan, M., Raleigh, D. P. and Muir, T. W. (2011) Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction. Nat. Chem. Biol. 7, 113-119 CrossRef PubMed
58. Moyal, L., Lerenthal, Y., Gana-Weisz, M., Mass, G., So, S., Wang, S. Y., Eppink, B., Chung, Y. M., Shalev, G., Shema, E. et al. (2011) Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Mol. Cell 41, 529-542 CrossRef PubMed
59. Nakamura, K., Kato, A., Kobayashi, J., Yanagihara, H., Sakamoto, S., Oliveira, D. V., Shimada, M., Tauchi, H., Suzuki, H., Tashiro, S. et al. (2011) Regulation of homologous recombination by RNF20-dependent H2B ubiquitination. Mol. Cell 41, 515-528 CrossRef PubMed
60. Wu, J., Chen, Y., Lu, L. Y., Wu, Y., Paulsen, M. T., Ljungman, M., Ferguson, D. O. and Yu, X. (2011) Chfr and RNF8 synergistically regulate ATM activation. Nat. Struct. Mol. Biol. 18, 761-768 CrossRef PubMed
61. Rea, S., Xouri, G. and Akhtar, A. (2007) Males absent on the first (MOF): from flies to humans. Oncogene 26, 5385-5394 CrossRef PubMed (Pubitemid 47255921)
62. Xia, B., Dorsman, J. C., Ameziane, N., de Vries, Y., Rooimans, M. A., Sheng, Q., Pals, G., Errami, A., Gluckman, E., Llera, J. et al. (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat. Genet. 39, 159-161 CrossRef PubMed (Pubitemid 46184344)
63. Serra, A., Eirich, K., Winkler, A. K., Mrasek, K., Gohring, G., Barbi, G., Cario, H., Schlegelberger, B., Pokora, B., Liehr, T. et al. (2012) Shared copy number variation in simultaneous nephroblastoma and neuroblastoma due to Fanconi anemia. Mol. Syndromol. 3, 120-130 CrossRef PubMed
64. Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M. et al. (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat. Genet. 39, 162-164 CrossRef PubMed (Pubitemid 46184345)
65. Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T. et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39, 165-167 CrossRef PubMed (Pubitemid 46184346)
66. Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C., Palmisano, E., Brune, K., Jaffee, E. M. et al. (2009) Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324, 217 CrossRef PubMed
67. Dansonka-Mieszkowska, A., Kluska, A., Moes, J., Dabrowska, M., Nowakowska, D., Niwinska, A., Derlatka, P., Cendrowski, K. and Kupryjanczyk, J. (2010) A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med. Genet. 11, 20 CrossRef PubMed
68. Cao, A. Y., Huang, J., Hu, Z., Li, W. F., Ma, Z. L., Tang, L. L., Zhang, B., Su, F. X., Zhou, J., Di, G. H. et al. (2009) The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res. Treat. 114, 457-462 CrossRef PubMed
69. Garcia, M. J., Fernandez, V., Osorio, A., Barroso, A., Llort, G., Lazaro, C., Blanco, I., Caldes, T., de la Hoya, M., Ramon, Y. C. T. et al. (2009) Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families. Breast Cancer Res. Treat. 113, 545-551 CrossRef PubMed
70. Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjakoski, K., Mannermaa, A., Kallioniemi, A., Pylkas, K., Karppinen, S. M., Rapakko, K. et al. (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446, 316-319 CrossRef PubMed (Pubitemid 46426155)
71. Tischkowitz, M., Xia, B., Sabbaghian, N., Reis-Filho, J. S., Hamel, N., Li, G., van Beers, E. H., Li, L., Khalil, T., Quenneville, L. A. et al. (2007) Analysis of PALB2/FANCN-associated breast cancer families. Proc. Natl. Acad. Sci. U.S.A. 104, 6788-6793 CrossRef PubMed (Pubitemid 47175579)
72. Peterlongo, P., Catucci, I., Pasquini, G., Verderio, P., Peissel, B., Barile, M., Varesco, L., Riboni, M., Fortuzzi, S., Manoukian, S. and Radice, P. (2011) PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer. Breast Cancer Res. Treat. 126, 825-828 CrossRef PubMed
73. Southey, M. C., Teo, Z. L., Dowty, J. G., Odefrey, F. A., Park, D. J., Tischkowitz, M., Sabbaghian, N., Apicella, C., Byrnes, G. B., Winship, I. et al. (2010) A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res. 12, R109 CrossRef PubMed
74. Sluiter, M., Mew, S. and van Rensburg, E. J. (2009) PALB2 sequence variants in young South African breast cancer patients. Fam. Cancer 8, 347-353 CrossRef PubMed
75. Erkko, H., Dowty, J. G., Nikkilä, J., Syrjakoski, K., Mannermaa, A., Pylkas, K., Southey, M. C., Holli, K., Kallioniemi, A., Jukkola-Vuorinen, A. et al. (2008) Penetrance analysis of the PALB2 c.1592delT founder mutation. Clin. Cancer Res. 14, 4667-4671 CrossRef PubMed
76. Casadei, S., Norquist, B. M., Walsh, T., Stray, S., Mandell, J. B., Lee, M. K., Stamatoyannopoulos, J. A. and King, M. C. (2011) Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res. 71, 2222-2229 CrossRef PubMed
77. Tischkowitz, M., Capanu, M., Sabbaghian, N., Li, L., Liang, X., Vallee, M. P., Tavtigian, S. V., Concannon, P., Foulkes, W. D., Bernstein, L. et al. (2012) Rare germline mutations in PALB2 and breast cancer risk: a population-based study. Hum. Mutat. 33, 674-680 CrossRef PubMed
78. Balia, C., Sensi, E., Lombardi, G., Roncella, M., Bevilacqua, G. and Caligo, M. A. (2010) PALB2: a novel inactivating mutation in a Italian breast cancer family. Fam. Cancer 9, 531-536 CrossRef PubMed
79. Tischkowitz, M., Sabbaghian, N., Hamel, N., Pouchet, C., Foulkes, W. D., Mes-Masson, A. M., Provencher, D. M. and Tonin, P. N. (2013) Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent. BMC Med. Genet. 14, 5 CrossRef PubMed
80. Blanco, A., de la Hoya, M., Balmana, J., Ramon y Cajal, T., Teule, A., Miramar, M. D., Esteban, E., Infante, M., Benitez, J., Torres, A. et al. (2012) Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer. Breast Cancer Res. Treat. 132, 307-315 CrossRef PubMed
81. Adank, M. A., van Mil, S. E., Gille, J. J., Waisfisz, Q. and Meijers-Heijboer, H. (2011) PALB2 analysis in BRCA2-like families. Breast Cancer Res. Treat. 127, 357-362 CrossRef PubMed
82. Ding, Y. C., Steele, L., Kuan, C. J., Greilac, S. and Neuhausen, S. L. (2011) Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res. Treat. 126, 771-778 CrossRef PubMed
83. Pakkanen, S., Wahlfors, T., Siltanen, S., Patrikainen, M., Matikainen, M. P., Tammela, T. L. and Schleutker, J. (2009) PALB2 variants in hereditary and unselected Finnish prostate cancer cases. J. Negat. Results Biomed. 8, 12 CrossRef PubMed
84. Bogdanova, N., Sokolenko, A. P., Iyevleva, A. G., Abysheva, S. N., Blaut, M., Bremer, M., Christiansen, H., Rave-Frank, M., Dork, T. and Imyanitov, E. N. (2011) PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Res. Treat. 126, 545-550 CrossRef PubMed
85. Wong-Brown, M. W., Avery-Kiejda, K. A., Bowden, N. A. and Scott, R. J. (2013) Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer. Int. J. Cancer 134, 301-305 CrossRef PubMed
86. Zheng, Y., Zhang, J., Niu, Q., Huo, D. and Olopade, O. I. (2012) Novel germline PALB2 truncating mutations in African American breast cancer patients. Cancer 118, 1362-1370 CrossRef PubMed
87. Teo, Z. L., Park, D. J., Provenzano, E., Chatfield, C. A., Odefrey, F. A., Nguyen-Dumont, T., kConFab, Dowty, J. G., Hopper, J. L., Winship, I. et al. (2013) Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families. Breast Cancer Res. 15, R17 CrossRef PubMed
88. Walsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A. M., Roeb, W., Agnew, K. J., Stray, S. M., Wickramanayake, A. et al. (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc. Natl. Acad. Sci. U.S.A. 108, 18032-18037 CrossRef PubMed
89. Phuah, S. Y., Lee, S. Y., Kang, P., Kang, I. N., Yoon, S. Y., Thong, M. K., Hartman, M., Sng, J. H., Yip, C. H., Taib, N. A. and Teo, S. H. (2013) Prevalence of PALB2 mutations in breast cancer patients in multi-ethnic Asian population in Malaysia and Singapore. PLoS ONE 8, e73638 CrossRef PubMed
90. Foulkes, W. D., Ghadirian, P., Akbari, M. R., Hamel, N., Giroux, S., Sabbaghian, N., Darnel, A., Royer, R., Poll, A., Fafard, E. et al. (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res. 9, R83 CrossRef PubMed
91. Prokofyeva, D., Bogdanova, N., Bermisheva, M., Zinnatullina, G., Hillemanns, P., Khusnutdinova, E. and Dork, T. (2012) Rare occurrence of PALB2 mutations in ovarian cancer patients from the Volga-Ural region. Clin. Genet. 82, 100-101 CrossRef PubMed
92. Kanchi, K. L., Johnson, K. J., Lu, C., McLellan, M. D., Leiserson, M. D., Wendl, M. C., Zhang, Q., Koboldt, D. C., Xie, M., Kandoth, C. et al. (2014) Integrated analysis of germline and somatic variants in ovarian cancer. Nat. Commun. 5, 3156 CrossRef PubMed
93. Wong, M. W., Nordfors, C., Mossman, D., Pecenpetelovska, G., Avery-Kiejda, K. A., Talseth-Palmer, B., Bowden, N. A. and Scott, R. J. (2011) BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. Breast Cancer Res. Treat. 127, 853-859 CrossRef PubMed
94. Villarroel, M. C., Rajeshkumar, N. V., Garrido-Laguna, I., De Jesus-Acosta, A., Jones, S., Maitra, A., Hruban, R. H., Eshleman, J. R., Klein, A., Laheru, D. et al. (2011) Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer. Mol. Cancer Ther. 10, 3-8 CrossRef PubMed
95. Tischkowitz, M. D., Sabbaghian, N., Hamel, N., Borgida, A., Rosner, C., Taherian, N., Srivastava, A., Holter, S., Rothenmund, H., Ghadirian, P. et al. (2009) Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. Gastroenterology 137, 1183-1186 CrossRef PubMed
96. Slater, E. P., Langer, P., Niemczyk, E., Strauch, K., Butler, J., Habbe, N., Neoptolemos, J. P., Greenhalf, W. and Bartsch, D. K. (2010) PALB2 mutations in European familial pancreatic cancer families. Clin. Genet. 78, 490-494 CrossRef PubMed
97. Hofstatter, E. W., Domchek, S. M., Miron, A., Garber, J., Wang, M., Componeschi, K., Boghossian, L., Miron, P. L., Nathanson, K. L. and Tung, N. (2011) PALB2 mutations in familial breast and pancreatic cancer. Fam. Cancer 10, 225-231 CrossRef PubMed
98. Rantakari, P., Nikkilä, J., Jokela, H., Ola, R., Pylkas, K., Lagerbohm, H., Sainio, K., Poutanen, M. and Winqvist, R. (2010) Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice. Hum. Mol. Genet. 19, 3021-3029 CrossRef PubMed
99. Bouwman, P., Drost, R., Klijn, C., Pieterse, M., van der Gulden, H., Song, J. Y., Szuhai, K. and Jonkers, J. (2011) Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression. J. Pathol. 224, 10-21 CrossRef PubMed
100. Bowman-Colin, C., Xia, B., Bunting, S., Klijn, C., Drost, R., Bouwman, P., Fineman, L., Chen, X., Culhane, A. C., Cai, H. et al. (2013) Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer. Proc. Natl. Acad. Sci. U.S.A. 110, 8632-8637 CrossRef PubMed
101. Tischkowitz, M. and Winqvist, R. (2011) Using mouse models to investigate the biological and physiological consequences of defects in the Fanconi anaemia/breast cancer DNA repair signalling pathway. J. Pathol. 224, 301-305 CrossRef PubMed
102. Nikkilä, J., Parplys, A. C., Pylkas, K., Bose, M., Huo, Y., Borgmann, K., Rapakko, K., Nieminen, P., Xia, B., Pospiech, H. and Winqvist, R. (2013) Heterozygous mutations in PALB2 cause DNA replication and damage response defects. Nat. Commun. 4, 2578 PubMed
103. Shen, Y., Rehman, F. L., Feng, Y., Boshuizen, J., Bajrami, I., Elliott, R., Wang, B., Lord, C. J., Post, L. E. and Ashworth, A. (2013) BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency. Clin. Cancer Res. 19, 5003-5015 CrossRef PubMed
104. Feng, Z., Scott, S. P., Bussen, W., Sharma, G. G., Guo, G., Pandita, T. K. and Powell, S. N. (2011) Rad52 inactivation is synthetically lethal with BRCA2 deficiency. Proc. Natl. Acad. Sci. U.S.A. 108, 686-691 CrossRef PubMed
105. Lok, B. H., Carley, A. C., Tchang, B. and Powell, S. N. (2013) RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination. Oncogene 32, 3552-3558 CrossRef PubMed
106. Hellebrand, H., Sutter, C., Honisch, E., Gross, E., Wappenschmidt, B., Schem, C., Deissler, H., Ditsch, N., Gress, V., Kiechle, M. et al. (2011) Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Hum. Mutat. 32, E2176-E2188 CrossRef PubMed
107. Castera, L., Krieger, S., Rousselin, A., Legros, A., Baumann, J. J., Bruet, O., Brault, B., Fouillet, R., Goardon, N., Letac, O. et al. (2014) Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur. J. Hum. Genet., doi: 10.1038/ejhg.2014.16
108. Fernandes, P. H., Saam, J., Peterson, J., Hughes, E., Kaldate, R., Cummings, S., Theisen, A., Chen, S., Trost, J. and Roa, B. B. (2014) Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer. Cancer 120, 963-967 CrossRef PubMed
109. Pern, F., Bogdanova, N., Schürmann, P., Lin, M., Ay, A., Länger, F., Hillemanns, P., Christiansen, H., Park-Simon, T. W. and Dörk, T. (2012) Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer. PLoS ONE 7, e47993 CrossRef PubMed
110. Catucci, I., Peterlongo, P., Ciceri, S., Colombo, M., Pasquini, G., Barile, M., Bonanni, B., Verderio, P., Pizzamiglio, S., Foglia, C. et al. (2014) PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo. Genet. Med., doi: 10.1038/gim.2014.13 CrossRef
111. Southey, M. C., Teo, Z. L. and Winship, I. (2013) PALB2 and breast cancer: ready for clinical translation!. Appl. Clin. Genet. 6, 43-52 CrossRef PubMed
112. Heikkinen, T., Kärkkäinen, H., Aaltonen, K., Milne, R. L., Heikkilä, P., Aittomäki, K., Blomqvist, C. and Nevanlinna, H. (2009) The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin. Cancer Res. 15, 3214-3222 CrossRef PubMed
113. Papi, L., Putignano, A. L., Congregati, C., Piaceri, I., Zanna, I., Sera, F., Morrone, D., Genuardi, M. and Palli, D. (2010) A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam. Cancer 9, 181-185 CrossRef PubMed